Trial Profile
A Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled Dose-Ranging Clinical Study to Evaluate the Safety and Efficacy of ASC-J9 Cream Applied Twice Daily for 12 Weeks for the Treatment of Facial Acne Vulgaris
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 May 2014
Price :
$35
*
At a glance
- Drugs ASCJ 9 (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors AndroScience Corporation
- 14 May 2014 New trial record